Corporate News
-
On August 23rd, the winners of the HICOOL 2024 Global Entrepreneurship Competition were announced at the HICOOL 2024 Global Entrepreneurs Summit. The "Pioneering Application of Epigenetics in Reproductive Medicine" project by Nuwa Life won the third prize! In this grand gathering of global wisdom, we competed with 7,406 projects and 9,700 top innovators from 124 countries and regions, showcasing our strength and innovative spirit. Receiving recognition on such an international stage is a high affirmation of our potential for future development, and we are deeply honored. We thank every partner who supports us and every team member for their hard work and relentless pursuit. It is your creativity and efforts that have made this moment possible. This honor belongs to each of us and is the result of our joint struggle. We will continue to uphold the spirit ...
-
In December 2021, Guangzhou Nvwa Life Technology Co., Ltd. signed strategic cooperation agreements with CITIC Xiangya Genetics and Reproductive Specialist Hospital, the University of Hong Kong Shenzhen Hospital, and Shenyang Shengjing Hospital, aiming to cooperate in national scientific programs, research and development, and clinical trials.
-
The 2021 Huangpu District Leading Talent Competition was officially launched on October 25. High-level technology talents from 79 companies in the district competed for the award. After rounds of fierce competition, the founder of Guangzhou Nvwa Life Technology Co., Ltd. was selected as one of the awardees in Huangpu District, Guangzhou.
-
21st October, 2021, the biomedical final competition of the 10th China and the sixth Guangzhou Innovation and Entrepreneurship Competition was held in Huangpu District. Guangzhou Nvwa Life Technology Co., Ltd. was awarded the third out of 122 companies in biomedical field.
-
On 18th August,2021, Guangzhou NVWA life Technology Co., Ltd. , a new generation assisted reproductive technology innovation company (hereinafter referred to as “Nvwa life”) has successfully completed tens of millions of RMB in angel round financing, exclusively led by JUE Capital. In China, the low birth rate has become a major concern for China’s future economic and social development. With the implementation of supportive policies for the second and third child, many related fields have attracted attention, and the assisted reproductive market has become ont of the most attractive. The political bureau of central committee of Chinese Communist Party held a meeting to deliberate on The Decision On Optimization Of Reproduction Policy To Advance Population For Long-term and Balanced Development, on 31st May,2021. The meeting poi...